New technique creates 'nearly pure drug' for injection
Researchers have developed an “easy-to-adopt” process for removing excess additives from injectable drugs.
Researchers have developed an “easy-to-adopt” process for removing excess additives from injectable drugs.
According to the most recent Biopharma CEO Confidence Index, CEOs are shifting their focus back to their pipelines and have plans to increase outsourcing.
Ajinomoto Althea has been granted a US patent for a whole antibody crystallization method that is faster at producing stable, biologically-active crystals than current techniques.